BLLN
BillionToOne Reports Q2 2026 Revenue of $109.4M
The company reported a 64% increase in Q2 revenue, driven by growth in both prenatal and oncology testing. Management reiterated full-year guidance for $450M to $465M in revenue.
BLLN news
Latest 1 stories · newest Aug 5, 2026
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same BLLN feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/BLLN/newsSTART FREE